E
Zentalis Pharmaceuticals, Inc. ZNTL
$1.77 -$0.04-2.21%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -8.43% 7.01% -3.84% 46.93% 32.81%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -17.99% 11.65% 0.57% 31.24% 15.73%
Operating Income 17.99% -11.65% 61.87% -31.24% -15.73%
Income Before Tax 27.61% 22.23% 116.12% -10.35% -1.56%
Income Tax Expenses -187.10% 143.97% 32.41% 62.50% 119.50%
Earnings from Continuing Operations 27.70% 21.58% 115.87% -10.83% -1.91%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -34.88% 69.23% -87.88%
Net Income 27.68% 21.55% 115.93% -10.82% -2.07%
EBIT 17.99% -11.65% 61.87% -31.24% -15.73%
EBITDA 18.05% -11.75% 62.16% -31.50% -15.89%
EPS Basic 28.19% 32.87% 113.31% 9.05% 17.88%
Normalized Basic EPS 28.09% 17.45% 113.56% -3.13% 18.08%
EPS Diluted 28.19% 32.87% 113.08% 9.05% 17.88%
Normalized Diluted EPS 28.09% 17.45% 113.50% -3.13% 18.08%
Average Basic Shares Outstanding 0.71% 16.86% 19.60% 21.84% 24.30%
Average Diluted Shares Outstanding 0.71% 16.86% 20.10% 21.84% 24.30%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings